Search results
The past three years for Sutro Biopharma (NASDAQ:STRO) investors has not been profitable
Simply Wall St. via Yahoo Finance· 3 hours agoEvery investor on earth makes bad calls sometimes. But you want to avoid the really big losses like...
Sutro Biopharma, Inc. (STRO) Reports Q3 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoSutro Biopharma, Inc. (STRO) delivered earnings and revenue surprises of -146.67% and 121.56%,...
Sutro Biopharma, Inc.'s (NASDAQ:STRO) Share Price Boosted 48% But Its Business Prospects Need A Lift...
Simply Wall St. via Yahoo Finance· 5 months agoSutro Biopharma, Inc. (NASDAQ:STRO) shares have had a really impressive month, gaining 48% after a...
Sutro Biopharma, Inc. (STRO) Expected to Beat Earnings Estimates: Should You Buy?
Zacks via Yahoo Finance· 2 years agoSutro Biopharma, Inc. (STRO) possesses the right combination of the two key ingredients for a likely...
Sutro Biopharma, Inc. (NASDAQ:STRO) insider upped their holding by 4.3% earlier this year
Simply Wall St. via Yahoo Finance· 1 year agoLooking at Sutro Biopharma, Inc.'s (NASDAQ:STRO ) insider transactions over the last year, we can...
Sutro Biopharma, Inc. (STRO) Soars 11.3%: Is Further Upside Left in the Stock?
Zacks via Yahoo Finance· 1 year agoSutro Biopharma, Inc. (STRO) saw its shares surge in the last session with trading volume being...
Is Sutro Biopharma (NASDAQ:STRO) Using Too Much Debt?
Simply Wall St. via Yahoo Finance· 2 years agoSome say volatility, rather than debt, is the best way to think about risk as an investor, but...
Sutro Biopharma (STRO) Up 50% on Cancer Treatment Collaboration
Zacks via Yahoo Finance· 2 years agoSutro Biopharma (STRO) inks a partnership and licensing deal with Astellas Pharma to discover and...
Investors in Sutro Biopharma (NASDAQ:STRO) have unfortunately lost 51% over the last three years
Simply Wall St. via Yahoo Finance· 12 months agoSutro Biopharma, Inc. (NASDAQ:STRO) shareholders should be happy to see the share price up 15% in...
Sutro Biopharma Inc (STRO) Reports Q3 2023 Financial Results and Business Updates
GuruFocus.com via Yahoo Finance· 6 months agoSutro Biopharma Inc (NASDAQ:STRO) released its 8-K filing on November 13, 2023, detailing...